We infer from our findings that the myeloid phenotype of the neoplasms that generally develop in mice transplanted with E2A-PBX1-expressing bone marrow is explained by a profound reduction of T- and B-lymphoid potential that is imposed early, prior to the CLP stage, coupled with retention of myeloid lineage potential. This evidence concerns the gene PBX1 and neoplasm.